Michael Vaezi
Overview
Explore the profile of Michael Vaezi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
761
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yadavalli C, Upparahalli Venkateshaiah S, Verma A, Kathera C, Duncan P, Vaezi M, et al.
Cells
. 2024 Feb;
13(4.
PMID: 38391908
Background And Aims: Ultrasonography has shown that eosinophils accumulate in each segment of the esophageal mucosa in human EoE, ultimately promoting esophageal motility dysfunction; however, no mechanistic evidence explains how...
2.
Dasarathy D, Vaezi M, Patel D
Expert Rev Gastroenterol Hepatol
. 2023 Dec;
18(1-3):13-24.
PMID: 38145413
Introduction: Gastroesophageal reflux disease (GERD) is the most common diagnosis seen in outpatient gastroenterology clinics. The diagnosis is made by a variable combination of symptoms, response to acid suppressive therapy,...
3.
Jacobse J, Brown R, Revetta F, Vaezi M, Buendia M, Williams C, et al.
J Allergy Clin Immunol
. 2023 Oct;
153(3):759-771.
PMID: 37852329
Background: Eosinophilic esophagitis (EoE) is a chronic immune mediated inflammatory disorder of the esophagus. It is still unknown why children and adults present differently, and there is little evidence about...
4.
Fass R, Vaezi M, Sharma P, Yadlapati R, Hunt B, Harris T, et al.
Aliment Pharmacol Ther
. 2023 Sep;
58(10):1016-1027.
PMID: 37750406
Background: Non-erosive reflux disease (NERD) symptoms are often episodic, making on-demand treatment an attractive treatment approach. Aims: We compared the efficacy and safety of on-demand vonoprazan versus placebo in patients...
5.
Dicpinigaitis P, Morice A, Smith J, Sher M, Vaezi M, Guilleminault L, et al.
Lung
. 2023 Jun;
201(3):255-266.
PMID: 37261531
Introduction: The PAGANINI study evaluated the efficacy and safety of the selective P2X3 antagonist eliapixant in patients with refractory chronic cough (RCC). Methods: PAGANINI was a randomized, double-blind, parallel-group, placebo-controlled,...
6.
Yadlapati R, Gyawali C, Carlson D, Pandolfino J, Fass R, Khan A, et al.
Neurogastroenterol Motil
. 2022 Dec;
35(3):e14505.
PMID: 36480408
Background: The functional lumen imaging probe (FLIP) evaluates esophagogastric junction (EGJ) opening and esophageal contractility. Both post hoc and real-time analyses are possible, but reproducibility and reliability of analysis remain...
7.
Pandolfino J, Carlson D, McGarva J, Kahrilas P, Vaezi M, Katzka D, et al.
Aliment Pharmacol Ther
. 2022 Sep;
56(10):1434-1443.
PMID: 36127750
Background: Achalasia is a debilitating major motor disorder of the oesophagus. Hypervigilance and symptom-specific anxiety substantially impact dysphagia symptom reporting, and quality of life is a critical patient outcome. Earlier...
8.
Basnayake C, Geeraerts A, Pauwels A, Koek G, Vaezi M, Vanuytsel T, et al.
Aliment Pharmacol Ther
. 2021 Jul;
54(6):755-778.
PMID: 34313333
Background: The prevalence of duodenogastroesophageal reflux (DGER) and its effect on symptoms and oesophageal lesions in gastroesophageal reflux disease (GERD) is unclear. Aims: To conduct a systematic review to determine...
9.
Khan A, Yadlapati R, Gonlachanvit S, Katzka D, Park M, Vaezi M, et al.
Neurogastroenterol Motil
. 2021 Jun;
33(7):e14182.
PMID: 34190376
The recommended diagnostic criteria for achalasia have been recently updated by Chicago Classification version 4.0 (CCv4.0), the widely accepted classification scheme for esophageal motility disorders using metrics from high-resolution manometry...
10.
Mutha P, Fasullo M, Chu S, Schubert M, Zfass A, Cooper P, et al.
Dig Dis Sci
. 2021 May;
67(5):1773-1782.
PMID: 33939145
Introduction: Epithelial barrier function (EBF) disruption is a key mechanism underlying gastroesophageal reflux disease (GERD). Our aim was to assess whether two novel technologies, probe-based confocal laser endomicroscopy (pCLE) and...